Centro de Investigaciones Metabólicas (CINME) S.A. - CABA, Buenos Aires

CINME abre sus puertas en el 2007. Su misión es mejorar la calidad de vida de sus pacientes, a través de la atención médica asistencial humana e integral, siendo un centro educador para la comunidad y aportando datos cualitativos al avance científico en el marco de la investigación clínica. Hemos incorporado nuevas áreas terapéuticas en el campo de la salud, buscando ser en cada una un centro modelo para el diagnóstico y tratamiento de enfermedades, y al mismo tiempo de referencia en el campo de la investigación clínica. Teniendo como ideal la excelencia, hemos hecho especial énfasis en los procesos que nos aportan altos estándares de calidad en nuestro trabajo. Por ello, en el 2019 certificamos en calidad en los procesos de investigación clínica a través de IRAM-ISO 9001-2015.

Viamonte 2278, C1056ABJ Cdad. Autónoma de Buenos Aires, Argentina

Websitehttp://www.cinme.com.ar

Select an option

I am a doctor

I am a sponsor

Specializations

Dermatitis atópica

Diabetes

Hepatitis autoinmune

Colitis ulcerosa

Enfermedad de Crohn

Fibrosis pulmonar

Fibrosis pulmonar idiopática

Cardiovascular

Nefropatía

Our team

Medical staff

Gisela Burattini

Daniela Saravia

Lucia Escalona Barrios

Emilia Pastormerlo

Luisa Ramallo

Solana Alderete Morillo

Camila Rotta

Gabriela Romero

Catalina Hermida

Ana Maria Freuler

Nerina Samanta Rodriguez Giambagli

Gonzalo Saenz

Alejandra Romeo

Angela Romero Zarante

Mónica Rondinón

Liliana González

Mariana Abal

Ricardo Galimberti

Maria Laura Galimberti

Griselda Russo

María Otaola

Maria Otaola

Fernando Halac

Raquel Analia González

Estanislao Jesus Gomez

Maria Julia Garay

Gonzalo Saenz

Alberto Casey

Alberto Lorenzo Casey

Daniela Camargo

Daniel Seinhart

Federico Carlos Perez Manghi

Maria de Lourdes Figuerola

María Margarita Anders

Estanislao Gómez

Adriana Ellenberg

Mariana Paula Blas

Maria Otaola

Lucas Manghi

Open studies

Obesity

The Effect of Retatrutide Once Weekly on Cardiovascular Outcomes and Kidney Outcomes in Adults Living With Obesity (TRIUMPH-Outcomes) - TRIUMPH-OUTCOMES - Eli Lilly and Company

A Study of Tirzepatide in Adolescents With Obesity and Weight-Related Comorbidities (SURMOUNT-ADOLESCENTS-2) - SURMOUNT-ADOLESCENTS-2 - Eli Lilly and Company

A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight - Eli Lilly and Company

Pulmonary fibrosis

A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Idiopathic Pulmonary Fibrosis - ALOFT-IPF - Bristol-Myers Squibb

A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Progressive Pulmonary Fibrosis - ALOFT-PPF - Bristol-Myers Squibb

Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF) - TETON-PPF - United Therapeutics

Alzheimer disease

Efficacy and Safety of GSK4527226 [AL101] in Participants With Early Alzheimer's Disease - PROGRESS-AD - GlaxoSmithKline

A Study of Donanemab (LY3002813) in Participants With Early Symptomatic Alzheimer's Disease (TRAILBLAZER-ALZ 5) - TRAILBLAZER-ALZ 5 - Eli Lilly and Company

Renal disease

The Effect of Retatrutide Once Weekly on Cardiovascular Outcomes and Kidney Outcomes in Adults Living With Obesity (TRIUMPH-Outcomes) - TRIUMPH-OUTCOMES - Eli Lilly and Company

A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease - NN C0519-0130 - Novo Nordisk A/S

Alopecia

A Study of Baricitinib (LY3009104) in Children From 6 Years to Less Than 18 Years of Age With Alopecia Areata - BRAVE-AA-PEDS - Eli Lilly and Company

Asthma

A Study to Assess the Effect of Dexpramipexole in Adolescents and Adults With Severe Eosinophilic Asthma. - EXHALE-2 - Areteia Therapeutics

Breast Cancer

Study of Belzutifan (MK-6482) Plus Fulvestrant for ER+/HER2- Metastatic Breast Cancer (MK-6482-029/LITESPARK-029) - MK-6482-029 LITESPARK-029 - Merck Sharp & Dohme LLC

Cardiovascular disease

A Study to Investigate the Effect of Lepodisiran on the Reduction of Major Adverse Cardiovascular Events in Adults With Elevated Lipoprotein(a) - ACCLAIM-Lp(a) - ACCLAIM-Lp(a) - Eli Lilly and Company

Dermatitis

A Study to Evaluate the Efficacy and Safety of Subcutaneous Amlitelimab on Background Topical Corticosteroids Therapy in Participants Aged 12 Years and Older With Moderate-to-severe AD Who Have Had an Inadequate Response to Prior Biologic Therapy or an Oral JAK Inhibitor - AQUA - Sanofi

Diabetes

Effect of Retatrutide Compared With Placebo in Participants With Type 2 Diabetes and Moderate or Severe Renal Impairment, With Inadequate Glycemic Control on Basal Insulin, With or Without Metformin and/or SGLT2 Inhibitor (TRANSCEND-T2D-3) - TRANSCEND-T2D-3 - Eli Lilly and Company

Elevated Lipoprotein A

A Study to Investigate the Effect of Lepodisiran on the Reduction of Major Adverse Cardiovascular Events in Adults With Elevated Lipoprotein(a) - ACCLAIM-Lp(a) - ACCLAIM-Lp(a) - Eli Lilly and Company

Fatty Liver

Study to Evaluate the Efficacy and Safety of K-877-ER and CSG452 in Participants With NASH With Liver Fibrosis - Kowa Research Institute, Inc.

Fatty liver/nash

Study to Evaluate the Efficacy and Safety of K-877-ER and CSG452 in Participants With NASH With Liver Fibrosis - Kowa Research Institute, Inc.

Head and neck cancer

A Platform Study of Novel Immunotherapy Combinations as First-Line Treatment in Participants With PD-L1 Positive Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck- GALAXIES H&N-202 - GALAXIES H&N-202 - GlaxoSmithKline

Heart failure

A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure - EASi-HF - Boehringer Ingelheim

Lupus

A Study to Learn About the Safety of Litifilimab (BIIB059) Injections and Whether They Can Improve Symptoms of Adult Participants Who Have Systemic Lupus Erythematosus - TOPAZ-2 - Biogen

About usOur mission Our team Partners FAQs

Medical newsLatest news Studies Interviews Testimonials

ProductsUEPM Onco UEPM Physicians

LinksDownloads

Centro de Investigaciones Metabólicas (CINME) S.A. - CABA, Buenos Aires

Viamonte 2278, C1056ABJ Cdad. Autónoma de Buenos Aires, Argentina

Websitehttp://www.cinme.com.ar

Select an option

I am a doctor

I am a sponsor

Specializations

Dermatitis atópica

Diabetes

Hepatitis autoinmune

Colitis ulcerosa

Enfermedad de Crohn

Fibrosis pulmonar

Fibrosis pulmonar idiopática

Cardiovascular

Nefropatía

Our team

Medical staff

Gisela Burattini

Daniela Saravia

Lucia Escalona Barrios

Emilia Pastormerlo

Luisa Ramallo

Solana Alderete Morillo

Camila Rotta

Gabriela Romero

Catalina Hermida

Ana Maria Freuler

Nerina Samanta Rodriguez Giambagli

Gonzalo Saenz

Alejandra Romeo

Angela Romero Zarante

Mónica Rondinón

Liliana González

Mariana Abal

Ricardo Galimberti

Maria Laura Galimberti

Griselda Russo

María Otaola

Maria Otaola

Fernando Halac

Raquel Analia González

Estanislao Jesus Gomez

Maria Julia Garay

Gonzalo Saenz

Alberto Casey

Alberto Lorenzo Casey

Daniela Camargo

Daniel Seinhart

Federico Carlos Perez Manghi

Maria de Lourdes Figuerola

María Margarita Anders

Estanislao Gómez

Adriana Ellenberg

Mariana Paula Blas

Maria Otaola

Lucas Manghi

Open studies

Obesity

The Effect of Retatrutide Once Weekly on Cardiovascular Outcomes and Kidney Outcomes in Adults Living With Obesity (TRIUMPH-Outcomes) - TRIUMPH-OUTCOMES - Eli Lilly and Company

A Study of Tirzepatide in Adolescents With Obesity and Weight-Related Comorbidities (SURMOUNT-ADOLESCENTS-2) - SURMOUNT-ADOLESCENTS-2 - Eli Lilly and Company

A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight - Eli Lilly and Company

Pulmonary fibrosis

A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Idiopathic Pulmonary Fibrosis - ALOFT-IPF - Bristol-Myers Squibb

A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Progressive Pulmonary Fibrosis - ALOFT-PPF - Bristol-Myers Squibb

Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF) - TETON-PPF - United Therapeutics

Alzheimer disease

Efficacy and Safety of GSK4527226 [AL101] in Participants With Early Alzheimer's Disease - PROGRESS-AD - GlaxoSmithKline

A Study of Donanemab (LY3002813) in Participants With Early Symptomatic Alzheimer's Disease (TRAILBLAZER-ALZ 5) - TRAILBLAZER-ALZ 5 - Eli Lilly and Company

Renal disease

The Effect of Retatrutide Once Weekly on Cardiovascular Outcomes and Kidney Outcomes in Adults Living With Obesity (TRIUMPH-Outcomes) - TRIUMPH-OUTCOMES - Eli Lilly and Company

A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease - NN C0519-0130 - Novo Nordisk A/S

Alopecia

A Study of Baricitinib (LY3009104) in Children From 6 Years to Less Than 18 Years of Age With Alopecia Areata - BRAVE-AA-PEDS - Eli Lilly and Company

Asthma

A Study to Assess the Effect of Dexpramipexole in Adolescents and Adults With Severe Eosinophilic Asthma. - EXHALE-2 - Areteia Therapeutics

Breast Cancer

Study of Belzutifan (MK-6482) Plus Fulvestrant for ER+/HER2- Metastatic Breast Cancer (MK-6482-029/LITESPARK-029) - MK-6482-029 LITESPARK-029 - Merck Sharp & Dohme LLC

Cardiovascular disease

A Study to Investigate the Effect of Lepodisiran on the Reduction of Major Adverse Cardiovascular Events in Adults With Elevated Lipoprotein(a) - ACCLAIM-Lp(a) - ACCLAIM-Lp(a) - Eli Lilly and Company

Dermatitis

Diabetes

Elevated Lipoprotein A

A Study to Investigate the Effect of Lepodisiran on the Reduction of Major Adverse Cardiovascular Events in Adults With Elevated Lipoprotein(a) - ACCLAIM-Lp(a) - ACCLAIM-Lp(a) - Eli Lilly and Company

Fatty Liver

Study to Evaluate the Efficacy and Safety of K-877-ER and CSG452 in Participants With NASH With Liver Fibrosis - Kowa Research Institute, Inc.

Fatty liver/nash

Study to Evaluate the Efficacy and Safety of K-877-ER and CSG452 in Participants With NASH With Liver Fibrosis - Kowa Research Institute, Inc.

Head and neck cancer

Heart failure

A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure - EASi-HF - Boehringer Ingelheim

Lupus

A Study to Learn About the Safety of Litifilimab (BIIB059) Injections and Whether They Can Improve Symptoms of Adult Participants Who Have Systemic Lupus Erythematosus - TOPAZ-2 - Biogen

About usOur mission Our team Partners FAQs

Medical newsLatest news Studies Interviews Testimonials

ProductsUEPM Onco UEPM Physicians

LinksDownloads